<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Guides</title>
	<atom:link href="http://i-base.info/guides/feed" rel="self" type="application/rss+xml" />
	<link>http://i-base.info/guides</link>
	<description>HIV i-Base</description>
	<lastBuildDate>Thu, 23 May 2013 12:41:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
		<item>
		<title>darunavir</title>
		<link>http://i-base.info/guides/3555</link>
		<comments>http://i-base.info/guides/3555#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3555</guid>
		<description><![CDATA[(800 mg formulation shown) da-RUN-na-veer Darunavir (tradename Prezista in Europe, developed as TMC-114) is a protease inhibitor that needs to be taken with a separate dose of ritonavir to boost drug levels (by 14 times). Standard adult doses: different doses are currently recommended. If darunavir &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3555/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>efavirenz</title>
		<link>http://i-base.info/guides/734</link>
		<comments>http://i-base.info/guides/734#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://localhost.localdomain/wpmu/guides/?p=734</guid>
		<description><![CDATA[ee-FAV-eer-enz Efavirenz (tradenames Sustiva or Stocrin in some other European countries) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). During 2014 generic formulations of efavirenz may be used in the UK with will have a different brand name, a different pill size and &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/734/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AZT (zidovudine)</title>
		<link>http://i-base.info/guides/3531</link>
		<comments>http://i-base.info/guides/3531#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3531</guid>
		<description><![CDATA[AY-zed-tee (zye-DOE-vue-deen) AZT (also called zidovudine, tradename Retrovir in Europe) is a nucleoside analogue. During 2013 generic formulations of AZT may be used in the UK with will have a different brand name, a different pill size and shape and different packaging. The &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3531/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>cobicistat</title>
		<link>http://i-base.info/guides/8930</link>
		<comments>http://i-base.info/guides/8930#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:30 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PK booster]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=8930</guid>
		<description><![CDATA[See: Quad (Stribild). Cobicistat is a PK (pharmacokinetic) booster that is used to increase levels of some other HIV meds. It is similar to ritonavir when that drug boosts some protease inhibitors. Unlike ritonavir, cobicistat does not directly work against HIV. Currently &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/8930/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>nevirapine</title>
		<link>http://i-base.info/guides/3543</link>
		<comments>http://i-base.info/guides/3543#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3543</guid>
		<description><![CDATA[Nevirapine 200 mg Nevirapine-PR (prolonged release) 400 mg nav-VYE-a-peen or nav-VIR-a-peen Nevirapine (tradename Viramune in Europe) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). During 2013 generic formulations of nevirapine may be used in the UK with will have a different brand name, &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3543/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>dolutegravir</title>
		<link>http://i-base.info/guides/8851</link>
		<comments>http://i-base.info/guides/8851#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:21 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Integrase inhibitors]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=8851</guid>
		<description><![CDATA[Picture not yet available. The research formulation and the proposed commercial formulation (both 50 mg) are both round with 9mm diameter, but the clinical tablet is slightly different, described as &#8216;deep convex&#8217;. dol-oo-TEG-rah-vir Dolutegravir is not currently licensed in Europe &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/8851/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>elvitegravir</title>
		<link>http://i-base.info/guides/8928</link>
		<comments>http://i-base.info/guides/8928#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:17 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Integrase inhibitors]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=8928</guid>
		<description><![CDATA[See Quad (Stribild).]]></description>
		<wfw:commentRss>http://i-base.info/guides/8928/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ddI (didanosine)</title>
		<link>http://i-base.info/guides/3529</link>
		<comments>http://i-base.info/guides/3529#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3529</guid>
		<description><![CDATA[dee-dee-EYE (dye-DAN-o-seen) ddI EC, also called didanosine (tradename Videx in Europe), is a nucleoside analogue. The EC stands for &#8216;enteric coating&#8217; as this slow-release capsule formulation replaced an earlier tablet. During 2013 generic formulations of ddI may be used in the UK &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3529/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quad (Stribild)</title>
		<link>http://i-base.info/guides/8841</link>
		<comments>http://i-base.info/guides/8841#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:15 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Integrase inhibitors]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=8841</guid>
		<description><![CDATA[Kwod QUAD is not currently licensed in Europe or the UK but is used by some people in clinical research studies. QUAD was approved in the USA in August 2012 with the brand name Stribild). Quad (Stribild) is a 4-in-1 single &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/8841/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Introduction to combination therapy home</title>
		<link>http://i-base.info/guides/2473</link>
		<comments>http://i-base.info/guides/2473#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2473</guid>
		<description><![CDATA[Introduction to combination therapy What is combination therapy? How does it work? CD4 and viral load tests. When to start. Which drug. Side effects, adherence and resistance. April 2013.]]></description>
		<wfw:commentRss>http://i-base.info/guides/2473/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ritonavir</title>
		<link>http://i-base.info/guides/3557</link>
		<comments>http://i-base.info/guides/3557#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>
		<category><![CDATA[PK booster]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3557</guid>
		<description><![CDATA[New Meltrex tablet (non-refrigerated) Old (original) capsule (requires refrigeration) rih-TOHN-a-veer Ritonavir (tradename Norvir) is a protease inhibitor (PI) that is now only used to boost drug levels of some other PIs. Ritonavir boosting allows you to use a lower dose &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3557/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>maraviroc</title>
		<link>http://i-base.info/guides/3565</link>
		<comments>http://i-base.info/guides/3565#comments</comments>
		<pubDate>Mon, 01 Apr 2013 12:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Entry inhibitors]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3565</guid>
		<description><![CDATA[ma-RAV-veer-ok Maraviroc (tradenames Celsentri in Europe and Selzentry in the US) is a CCR5 inhibitor. Standard doses: 1 x 150, 300 or 600 mg tablet depending on the other drugs in the combination, Available as 150 mg and 300 mg &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3565/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Eviplera (rilpivirine + tenofovir + FTC)</title>
		<link>http://i-base.info/guides/5912</link>
		<comments>http://i-base.info/guides/5912#comments</comments>
		<pubDate>Sun, 03 Mar 2013 12:00:50 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[NNRTIs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=5912</guid>
		<description><![CDATA[Find out about this new all-in-one pill.]]></description>
		<wfw:commentRss>http://i-base.info/guides/5912/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV and pregnancy home</title>
		<link>http://i-base.info/guides/2501</link>
		<comments>http://i-base.info/guides/2501#comments</comments>
		<pubDate>Fri, 01 Mar 2013 12:00:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2501</guid>
		<description><![CDATA[HIV, pregnancy and women&#8217;s health Planning your pregnancy. HIV treatment when pregnant. Important monitoring tests. Stopping your baby getting HIV. After baby is born. March 2013.]]></description>
		<wfw:commentRss>http://i-base.info/guides/2501/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antiretroviral listing home</title>
		<link>http://i-base.info/guides/7369</link>
		<comments>http://i-base.info/guides/7369#comments</comments>
		<pubDate>Tue, 22 Jan 2013 12:10:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=7369</guid>
		<description><![CDATA[HIV meds Each med described with links to patient and prescribing info.]]></description>
		<wfw:commentRss>http://i-base.info/guides/7369/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV testing and risks of sexual transmission home</title>
		<link>http://i-base.info/guides/6356</link>
		<comments>http://i-base.info/guides/6356#comments</comments>
		<pubDate>Tue, 22 Jan 2013 12:00:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=6356</guid>
		<description><![CDATA[HIV testing and sexual transmission Sexual health for you and your partner. Understanding transmission risks. How and when to test. What the results mean. February 2013.]]></description>
		<wfw:commentRss>http://i-base.info/guides/6356/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Changing treatment home</title>
		<link>http://i-base.info/guides/2506</link>
		<comments>http://i-base.info/guides/2506#comments</comments>
		<pubDate>Tue, 01 Jan 2013 12:00:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2506</guid>
		<description><![CDATA[Changing treatment Second-line therapy and drug resistance. Why treatment stops working and when to change. February 2013.]]></description>
		<wfw:commentRss>http://i-base.info/guides/2506/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Truvada (tenofovir + FTC)</title>
		<link>http://i-base.info/guides/746</link>
		<comments>http://i-base.info/guides/746#comments</comments>
		<pubDate>Sun, 26 Aug 2012 09:00:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://localhost.localdomain/wpmu/guides/?p=746</guid>
		<description><![CDATA[tru-VAR-da Truvada is the tradename for a fixed dose combination of tenofovir and FTC. In resource-limited countries this is a white tablet with the same design. Standard adult dose: 1 tablet (containing 300 mg tenofovir + 200 mg FTC), once-daily. Truvada is &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/746/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combivir (AZT + 3TC)</title>
		<link>http://i-base.info/guides/3539</link>
		<comments>http://i-base.info/guides/3539#comments</comments>
		<pubDate>Sun, 26 Aug 2012 09:00:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3539</guid>
		<description><![CDATA[Pronounced: KOM-biv-veer Combivir is the European trade name for a fixed dose combination of AZT and 3TC. Combivir is no longer recommended as preferred choice for first therapy in the UK or the USA for people starting treatment. Standard adult dose: one tablet, twice-daily. &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/3539/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>rilpivirine</title>
		<link>http://i-base.info/guides/5904</link>
		<comments>http://i-base.info/guides/5904#comments</comments>
		<pubDate>Sun, 26 Aug 2012 09:00:45 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=5904</guid>
		<description><![CDATA[ril-PIV-vir-reen Rilpivirine  (tradename Edurant, developed as TMC-278) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Standard adult dose: 1 x 25 mg tablet, once daily &#8211; at the same time each day. Take with a meal &#8211; at least 500 kcal. &#8230;]]></description>
		<wfw:commentRss>http://i-base.info/guides/5904/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
